» Authors » V Lorusso

V Lorusso

Explore the profile of V Lorusso including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 164
Citations 1474
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lorusso V, Orsi D, Vaccari M, Ravera F, Santini E, Chondrou A, et al.
J Colloid Interface Sci . 2024 Aug; 677(Pt A):231-243. PMID: 39089129
Hypothesis: In order to understand the basic mechanisms affecting emulsion stability, the intrinsic dynamics of the drop population must be investigated. We hypothesize that transient ballistic motion can serve as...
2.
Drago A, Carbone M, Lorusso V, Moschetta M, Scardapane A, Lucarelli N, et al.
G Chir . 2019 Feb; 40(1):44-48. PMID: 30771798
Amyand's hernia consists in the protrusion of the vermiform appendix into an inguinal hernia sac and represents an uncommon condition with a difficult preoperative diagnosis to be recognized with clinical...
3.
Caruso G, Bonomo M, Valpiani G, Salvatori G, Gildone A, Lorusso V, et al.
Bone Joint Res . 2017 Aug; 6(8):481-488. PMID: 28790037
Objectives: Intramedullary fixation is considered the most stable treatment for pertrochanteric fractures of the proximal femur and cut-out is one of the most frequent mechanical complications. In order to determine...
4.
Hoefeler H, Duran I, Hechmati G, Garzon Rodriguez C, Luftner D, Ashcroft J, et al.
J Bone Oncol . 2016 Feb; 3(2):40-8. PMID: 26909296
Background: Skeletal-related events (SREs; pathologic fracture, radiation or surgery to bone, spinal cord compression) frequently occur in patients with advanced cancer with bone metastases/lesions. Limited data on the associated patient...
5.
Massari L, Osti R, Lorusso V, Setti S, Caruso G
J Biol Regul Homeost Agents . 2016 Jan; 29(4):1013-5. PMID: 26753669
The biophysical stimulation of bone and cartilage, using Pulsed ElectroMagnetic Fields (PEMF), covers many different aspects of bone formation and/or cartilage repair, such as healing of delayed or non-union of...
6.
Chaabane L, Tei L, Miragoli L, Lattuada L, von Wronski M, Uggeri F, et al.
Mol Imaging Biol . 2015 Apr; 17(6):819-28. PMID: 25875866
Purpose: A magnetic resonance imaging contrast agent based on a tetrameric Gd-DTPA-like system linked to a fibrin-targeting peptide (Gd-F) has been designed for in vivo tumor characterization. Procedures: Gd-F was...
7.
Passardi A, Nanni O, Tassinari D, Turci D, Cavanna L, Fontana A, et al.
Ann Oncol . 2015 Mar; 26(6):1201-1207. PMID: 25735317
Background: We report the results from a first-line phase III randomized clinical trial on metastatic colorectal cancer (mCRC) aimed at evaluating the effectiveness of adding bevacizumab (B) to standard first-line...
8.
Kirchin M, Lorusso V, Pirovano G
Br J Radiol . 2015 Feb; 88(1048):20140526. PMID: 25651409
Objective: To determine whether increased elimination of gadobenate ion via the hepatobiliary pathway might compensate for reduced/absent elimination via the urinary pathway in the event of compromised renal function, as...
9.
Lorusso V, Giotta F, Bordonaro R, Maiello E, Del Prete S, Gebbia V, et al.
Int J Oncol . 2014 Sep; 45(5):2137-42. PMID: 25176223
We conducted a phase III multicenter randomized trial to compare the efficacy of the combination of liposome encapsulated doxorubicin (Myocet(©)) plus either cyclophosphamide (MC) or vinorelbine (MV). Since July 2006,...
10.
Aapro M, Rugo H, Rossi G, Rizzi G, Borroni M, Bondarenko I, et al.
Ann Oncol . 2014 Mar; 25(7):1328-1333. PMID: 24603643
Background: Antiemetic guidelines recommend co-administration of agents that target multiple molecular pathways involved in emesis to maximize prevention and control of chemotherapy-induced nausea and vomiting (CINV). NEPA is a new...